Merit Medical Systems

MMSI · NASDAQ

$91.18+$1.22 (+1.36%)TodayMarket closed ·
Prev close $89.96

Latest news

  • Press releaseGlobe Newswire

    Merit Medical Announces Global Operations Leadership Transition

  • NewsAvi Kapoor

    These Analysts Increase Their Forecasts On Merit Medical Systems After Strong Q2 Results

  • Press releaseGlobe Newswire

    Merit Medical Reports Second Quarter 2026 Results And Updates Full-Year 2026 Guidance

  • News

    Merit Medical Systems Q1 2026 Earnings Call Transcript

  • News

    Merit Medical Systems Q1 Adj. EPS $0.94 Beats $0.83 Estimate, Sales $381.877M Beat $377.632M Estimate

  • Press releaseGlobe Newswire

    Merit Medical Reports First Quarter 2026 Results and Updates Full-Year Guidance

  • News

    Earnings Scheduled For April 30, 2026

  • News

    Merit Medical Systems Acquires View Point Medical For ~$140M

  • Press releaseGlobe Newswire

    Merit Medical Acquires View Point Medical, Inc., expanding the Merit Therapeutic Oncology Portfolio

  • Press releasePRNewswire

    Medtronic and Merit Medical Systems enter into agreement to offer new, FDA-cleared ViaVerte™ system, a basivertebral nerve ablation treatment for chronic vertebrogenic lower-back pain

  • News

    5 Analysts Have This To Say About Merit Medical Systems

  • News

    Merit Medical Systems Q4 Adj. EPS $1.04 Beats $0.95 Estimate, Sales $393.936M Beat $389.874M Estimate

  • Press releaseGlobe Newswire

    Merit Medical Reports Fourth Quarter and Full Year 2025 Results and Issues Fiscal Year 2026 Guidance

  • Press releaseGlobe Newswire

    Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025

  • Press releaseGlobe Newswire

    Merit Medical Reports Third Quarter 2025 Results and Updates Full-Year Guidance

  • Press releasePRNewswire

    PENTAX Medical Announces Sale of C2 CryoBalloon™ Product Line to Merit Medical Systems through Asset Purchase Agreement

  • Press releaseGlobe Newswire

    Merit Medical Signs Asset Purchase Agreement with PENTAX Medical to Acquire C2 CryoBalloon Technology

  • Press releaseGlobe Newswire

    Merit Medical Reports Second Quarter 2025 Results and Updates Full-Year Guidance

  • NewsRishabh Mishra

    US Stocks Likely To Open Mixed As Trump Issues Tariff Letters: Experts Peg AI Investments As 'Durable Drivers Of Returns'

  • Press releaseGlobe Newswire

    Merit Medical Names Martha Aronson as New President and Chief Executive Officer

  • Press releaseGlobe Newswire

    Merit Medical to Present at the 2024 Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Congress

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.